About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Organ, tissue and cell donation is one of the greatest acts of generosity and solidarity that an individual can do, and we strive to ensure that the maximum number of people benefit from it.
We are a multidisciplinary group of professionals who investigate the search for innovative strategies to optimize the process of donation, preservation, processing, and transplantation of organs, tissues and cells in order to increase their availability, expand their functionality, and improve their quality and safety, so they contribute to better health outcomes.
We deepen into the characterization of the damaging mechanisms that operate in the ischemia-reperfusion process during donation and transplantation in order to develop practices that allow us to prevent, minimize or treat them.
IP: Alberto Sandiumenge Camps
IP: Maria Jose Soler Romeo Collaborators: Alejandra Gabaldon Dominguez, Mario Alonso Narvaez Barros, Pamela Dominguez Baez, Irene Martinez Diaz, Sheila Bermejo Garcia, Alejandra Planas Vilaseca, Concepció Jacobs Cachá, Juan Carlos León Román Funding agency: Instituto de Salud Carlos III Funding: 122210 Reference: PI21/01292 Duration: 01/01/2022 - 30/06/2026
The study shows that cell-free mitochondrial DNA does not directly reflect the injury caused by warm ischemia in the donor lung, but rather that its post-transplant levels are associated with the recipient’s inflammatory response.
The work of the multinational team, which has reviewed the records of more than one million patients who have received a new organ, has found significant differences between women and men
Divuit hores de programa solidari recull més de 8 milions d'euros per lluitar contra les malalties del cor. A Catalunya, una de cada quatre persones moren a causa d'una malaltia del cor o un ictus
